Skip to main content
Srikanth Ambati, MD, Pediatric Hematology & Oncology, New York, NY, Memorial Sloan Kettering Cancer Center

SrikanthReddyAmbatiMD

Pediatric Hematology & Oncology New York, NY

Pediatric Sarcoma Oncology

Assistant Attending, MSKCC

Dr. Ambati is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Ambati's full profile

Already have an account?

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterPost-Doctoral Fellowship, Pediatric Cancer/ Sarcomas, 2012 - 2014
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 2009 - 2012
  • Nicklaus Children's Hospital
    Nicklaus Children's HospitalResidency, Pediatrics, 2006 - 2009
  • Banaras Hindu University IOM
    Banaras Hindu University IOMClass of 2002

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2011 - 2026
  • UT State Medical License
    UT State Medical License 2009 - 2012
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Publications & Presentations

PubMed

Abstracts/Posters

  • Clinical Activity of REGN1979, a Bispecific Human, Anti-CD20 x Anti-CD3 Antibody, in Patients with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (B-NHL)
    Srikanth R. Ambati, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Emerging Clinical Activity of REGN1979, an Anti-CD20 x Anti‑CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Follicular Lymphoma (FL), Diffuse Large B-Cel... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Hospital Affiliations